-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
After reviewing the results of nearly 14,000 colorectal cancer patients, the researchers determined that ACE inhibitors, beta blockers, and thiazide diuretics were all associated with lower mortality
Researchers emphasize that more research is needed to confirm the connection between antihypertensive drugs and better treatment outcomes
Dr.
About colorectal cancer
Colorectal cancer is the third most common cancer in the United States
Hypertension is common in patients with colorectal cancer, but there are few studies on the potential impact of antihypertensive drugs on the prognosis of patients
Researchers have found that ACE inhibitors and thiazide diuretics seem to provide the most significant benefits for patient survival and prognosis, while calcium channel blockers do not seem to have similar benefits
Patient adherence to blood pressure regimens is also important: The researchers wrote in a new scientific paper outlining their findings: “Our findings show that patients who started using these drugs after diagnosis of stage I, II, or III CRC, Compared with patients who did not use these drugs, there is an association between increased adherence (blood pressure) drugs and lower.
Scientists are not sure whether the obvious benefits of antihypertensive drugs come from the drugs themselves or because they control the patient’s high blood pressure
Researchers pointed out that recently there have been several clinical trials testing the potential effects of antihypertensive drugs on other cancers
Balkrishnan said: "It is exciting that we can confirm that the results of Dr.
This work was supported by the University of Virginia Cancer Center and Fundaño de Amparo à Pesquisa do Estado de São Paulo
Journal Reference :
Rajesh Balkrishnan, Raj P.